Oral evidence transcript
| Published on: | Friday 15 April 2016 |
|---|---|
| Date: | Tuesday 22 March 2016 |
| Meeting on: | Tuesday 22 March 2016 |
| Part of event segment: | Untitled |
| Document ID: | 154729 |
| Citations: |
|
Committees
Work packages
-
EU regulation of the life sciences inquiry
Thursday 21 January 2016 - Wednesday 3 May 2017
Witnesses
-
Stuart Pritchard, EU Affairs Manager, Wellcome Trust, Dr Keith Ison, and Professor Berne Ferry, representing the Shelford Group; Dr Jacqueline Barry, Director of Regulatory Affairs, Cell and Gene Therapy Catapult, Paul Browning, Head of Regulatory Affairs, Brightwake Ltd, Darren Budd, Commercial Director - UK and Ireland, BASF, and Steve Bates, Chief Executive Officer, BioIndustry Association (at 3.00pm); Professor Roger Lemon, representing the Academy of Medical Sciences, and Sir John Skehel, Vice-President and Biological Secretary, The Royal Society (at 3.45pm).